| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.929 | 0.001 | 0.929 | Carbonic anhydrase XV inhibitor | 0.528 0.003 DBMET00923 | ||
| 0.832 | 0.002 | 0.832 | Carbonic anhydrase VI inhibitor | 0.351 0.005 DBMET00923 | ||
| 0.834 | 0.005 | 0.834 | Antiobesity | 0.721 0.009 DBMET00923 | ||
| 0.824 | 0.005 | 0.824 | Analgesic | 0.702 0.013 DBMET00923 | ||
| 0.802 | 0.002 | 0.802 | Carbonic anhydrase XIII inhibitor | 0.325 0.005 DBMET00923 | ||
| 0.791 | 0.002 | 0.791 | Carbonic anhydrase III inhibitor | 0.499 0.003 DBMET00923 | ||
| 0.674 | 0.005 | 0.674 | Anticonvulsant | 0.356 0.028 DBMET00923 | ||
| 0.544 | 0.002 | 0.544 | Carbonic anhydrase VB inhibitor | 0.309 0.003 DBMET00923 | ||
| 0.534 | 0.002 | 0.534 | Carbonic anhydrase V inhibitor | 0.278 0.004 DBMET00923 | ||
| 0.515 | 0.002 | 0.515 | Carbonic anhydrase VA inhibitor | 0.25 0.004 DBMET00923 | ||
| 0.346 | 0.003 | 0.346 | Carbonic anhydrase XIV inhibitor | 0.1 0.011 DBMET00923 | ||
| 0.337 | 0.003 | 0.337 | Carbonic anhydrase VII inhibitor | 0.09 0.011 DBMET00923 | ||
| 0.3 | 0.008 | 0.3 | Sodium channel (voltage-gated) blocker | 0.162 0.047 DBMET00923 | ||
| 0.292 | 0.011 | 0.292 | Sodium channel blocker | 0.154 0.055 DBMET00923 | ||
| 0.27 | 0.005 | 0.27 | Carbonic anhydrase IX inhibitor | 0.091 0.022 DBMET00923 | ||
| 0.261 | 0.004 | 0.261 | I kappa B kinase 1 inhibitor | |||
| 0.259 | 0.005 | 0.259 | Carbonic anhydrase inhibitor | 0.118 0.022 DBMET00923 | ||
| 0.258 | 0.019 | 0.258 | Cyclooxygenase 2 inhibitor | 0.105 0.097 DBMET00923 | ||
| 0.231 | 0.007 | 0.231 | ABCA1 expression enhancer | 0.177 0.012 DBMET00923 | ||
| 0.245 | 0.022 | 0.245 | Cyclooxygenase 1 inhibitor | 0.135 0.067 DBMET00923 | ||
| 0.248 | 0.027 | 0.248 | Cyclooxygenase inhibitor | 0.149 0.071 DBMET00923 | ||
| 0.224 | 0.005 | 0.224 | Lipase inhibitor | |||
| 0.213 | 0.005 | 0.213 | Carbonic anhydrase II inhibitor | 0.097 0.019 DBMET00923 | ||
| 0.209 | 0.005 | 0.209 | Carbonic anhydrase I inhibitor | 0.1 0.018 DBMET00923 | ||
| 0.246 | 0.085 | 0.246 | 5 Hydroxytryptamine uptake stimulant | 0.193 0.165 DBMET00923 | ||
| 0.206 | 0.054 | 0.206 | 5 Hydroxytryptamine 3E antagonist | 0.183 0.098 DBMET00923 | ||
| 0.164 | 0.015 | 0.164 | Electrolyte absorption antagonist | 0.114 0.042 DBMET00923 | ||
| 0.191 | 0.043 | 0.191 | MAO inhibitor | |||
| 0.193 | 0.047 | 0.193 | Diuretic | |||
| 0.165 | 0.029 | 0.165 | GABA receptor agonist | |||
| 0.226 | 0.092 | 0.226 | Aldehyde oxidase inhibitor | |||
| 0.131 | 0.008 | 0.131 | Bromodomain-containing protein 4 inhibitor | 0.117 0.01 DBMET00923 | ||
| 0.113 | 0.005 | 0.113 | Carbonic anhydrase IV inhibitor | 0.045 0.028 DBMET00923 | ||
| 0.256 | 0.149 | 0.256 | GABA C receptor rho-3 antagonist | |||
| 0.145 | 0.043 | 0.145 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.136 | 0.043 | 0.136 | MAO B inhibitor | |||
| 0.133 | 0.048 | 0.133 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.159 | 0.077 | 0.159 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.081 | 0.008 | 0.081 | CXC chemokine 1 receptor antagonist | 0.077 0.01 DBMET00923 | ||
| 0.116 | 0.048 | 0.116 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.078 | 0.012 | 0.078 | Mineralocorticoid receptor antagonist | |||
| 0.077 | 0.011 | 0.077 | Kinesin-like protein 1 inhibitor | |||
| 0.077 | 0.011 | 0.077 | Kinesin antagonist | |||
| 0.174 | 0.108 | 0.174 | Histone acetyltransferase inhibitor | |||
| 0.074 | 0.012 | 0.074 | Liver X receptor agonist | 0.05 0.023 DBMET00923 | ||
| 0.066 | 0.007 | 0.066 | Peroxisome proliferator-activated receptor delta antagonist | 0.042 0.013 DBMET00923 | ||
| 0.071 | 0.012 | 0.071 | Bromodomain-containing protein 3 inhibitor | 0.063 0.017 DBMET00923 | ||
| 0.096 | 0.045 | 0.097 | Bromodomain-containing protein 2 inhibitor | 0.097 0.044 DBMET00923 | DBMET00923 | |
| 0.138 | 0.088 | 0.138 | MAP kinase kinase 4 inhibitor | |||
| 0.065 | 0.017 | 0.065 | Dopamine D5 antagonist | |||
| 0.104 | 0.06 | 0.151 | Factor V inhibitor | 0.151 0.018 DBMET00923 | DBMET00923 | |
| 0.058 | 0.015 | 0.058 | Cytokine production stimulant | 0.048 0.036 DBMET00923 | ||
| 0.087 | 0.044 | 0.087 | CC chemokine 5 receptor agonist | |||
| 0.047 | 0.006 | 0.047 | Liver X receptor alpha antagonist | 0.035 0.012 DBMET00923 | ||
| 0.116 | 0.077 | 0.116 | MAP kinase kinase inhibitor | |||
| 0.049 | 0.01 | 0.049 | Liver X receptor antagonist | 0.035 0.017 DBMET00923 | ||
| 0.072 | 0.039 | 0.072 | Glutamate (mGluR7) antagonist | |||
| 0.05 | 0.022 | 0.063 | Factor X inhibitor | 0.063 0.017 DBMET00923 | DBMET00923 | |
| 0.073 | 0.045 | 0.073 | CDK1/cyclin B1 inhibitor | |||
| 0.063 | 0.036 | 0.063 | CDK9/cyclin T1 inhibitor | |||
| 0.039 | 0.018 | 0.047 | AMPA receptor agonist | 0.047 0.011 DBMET00923 | DBMET00923 | |
| 0.023 | 0.005 | 0.023 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.101 | 0.085 | 0.101 | CDK3/cyclin E inhibitor | |||
| 0.091 | 0.078 | 0.091 | GABA C receptor agonist | |||
| 0.037 | 0.028 | 0.138 | Factor VIIa inhibitor | 0.138 0.008 DBMET00923 | DBMET00923 | |
| 0.097 | 0.088 | 0.097 | Calcium channel (voltage-sensitive) blocker | |||
| 0.031 | 0.023 | 0.031 | Glucocorticoid antagonist | |||
| 0.047 | 0.041 | 0.047 | Carbonic anhydrase XII inhibitor | |||
| 0.041 | 0.037 | 0.041 | Glutamate (mGluR group III) antagonist | |||
| 0.047 | 0.043 | 0.047 | Potassium channel (Inward rectifier) activator | |||
| 0.026 | 0.022 | 0.026 | 5 Hydroxytryptamine 1D agonist | |||
| 0.043 | 0.039 | 0.043 | Purinergic P2X4 antagonist | |||
| 0.045 | 0.041 | 0.045 | Potassium channel (ATP-sensitive) activator | |||
| 0.083 | 0.082 | 0.083 | MAP kinase kinase 1 inhibitor | |||
| 0.031 | 0.031 | 0.055 | p53 inhibitor | 0.055 0.012 DBMET00923 | DBMET00923 | |
| 0.024 | 0.025 | 0.058 | Endothelin receptor antagonist | 0.058 0.009 DBMET00923 | DBMET00923 | |
| 0.065 | 0.082 | 0.079 | Vanilloid 4 agonist | 0.079 0.042 DBMET00923 | DBMET00923 | |
| 0.012 | 0.037 | 0.04 | Endothelin A receptor antagonist | 0.04 0.008 DBMET00923 | DBMET00923 | |
| 0.026 | 0.059 | 0.043 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.043 0.036 DBMET00923 | DBMET00923 | |
| 0.014 | 0.05 | 0.095 | Glycine transporter 1 inhibitor | 0.095 0.006 DBMET00923 | DBMET00923 | |
| 0.008 | 0.046 | 0.032 | Endothelin B receptor antagonist | 0.032 0.008 DBMET00923 | DBMET00923 | |
| 0.124 | 0.17 | 0.21 | Insulin sensitizer | 0.21 0.064 DBMET00923 | DBMET00923 | |
| 0.041 | 0.087 | 0.125 | Peroxisome proliferator-activated receptor gamma agonist | 0.125 0.019 DBMET00923 | DBMET00923 | |
| 0.021 | 0.077 | 0.073 | Macrophage elastase inhibitor | 0.073 0.014 DBMET00923 | DBMET00923 | |
| 0.082 | 0.181 | 0.212 | Anticoagulant | 0.212 0.049 DBMET00923 | DBMET00923 | |
| 0.062 | 0.181 | 0.12 | Caspase 3 inhibitor | 0.12 0.06 DBMET00923 | DBMET00923 | |
| 0.034 | 0.168 | 0.088 | Thrombin inhibitor | 0.088 0.034 DBMET00923 | DBMET00923 | |
| 0.082 | 0.316 | 0.211 | Beta lactamase inhibitor | 0.211 0.178 DBMET00923 | DBMET00923 | |
| 0.015 | 0.268 | 0.058 | Plasmin inhibitor | 0.058 0.029 DBMET00923 | DBMET00923 | |
| 0.045 | 0.328 | 0.125 | Phospholipase A2 inhibitor | 0.125 0.11 DBMET00923 | DBMET00923 | |
| 0.05 | 0.357 | 0.16 | Spasmolytic | 0.16 0.154 DBMET00401 | DBMET00401 | |
| 0.031 | 0.348 | 0.096 | Factor XII inhibitor | 0.096 0.041 DBMET00923 | DBMET00923 | |
| 0.038 | 0.408 | 0.177 | MAP3K9 inhibitor | 0.177 0.029 DBMET00401 | DBMET00401 | |
| 0.026 | 0.401 | 0.414 | Microtubule formation inhibitor | 0.414 0.001 DBMET00401 | DBMET00401 | |
| 0.029 | 0.443 | 0.118 | Cholinergic | 0.118 0.111 DBMET00401 | DBMET00401 | |
| 0.036 | 0.497 | 0.078 | Ca(v)3.1 blocker | 0.078 0.068 DBMET00923 | DBMET00923 | |
| 0.047 | 0.526 | 0.663 | Hypoxia-inducible factor 1 alpha inhibitor | 0.663 0.005 DBMET00401 | DBMET00401 | |
| 0.012 | 0.517 | 0.932 | Psychostimulant | 0.932 0.002 DBMET00401 | DBMET00401 | |
| 0.017 | 0.53 | 0.093 | Acetylcholine M3 receptor agonist | 0.093 0.05 DBMET00401 | DBMET00401 | |
| 0.008 | 0.53 | 0.074 | Plasminogen activator inhibitor | 0.074 0.029 DBMET00923 | DBMET00923 | |
| 0.011 | 0.584 | 0.075 | Prostaglandin F2 alpha antagonist | 0.075 0.027 DBMET00923 | DBMET00923 | |
| 0.009 | 0.607 | 0.032 | Purinergic P2Y2 antagonist | 0.032 0.026 DBMET00923 | DBMET00923 | |
| 0.007 | 0.71 | 0.152 | M17 leucyl aminopeptidase inhibitor | 0.152 0.054 DBMET00923 | DBMET00923 | |
| 0.004 | 0.764 | 0.059 | Acetylcholine M2 receptor agonist | 0.059 0.03 DBMET00401 | DBMET00401 | |
| 0.004 | 0.782 | 0.046 | Prostaglandin antagonist | 0.046 0.044 DBMET00923 | DBMET00923 | |
| 0.004 | 0.824 | 0.087 | Prostaglandin E2 antagonist | 0.087 0.018 DBMET00923 | DBMET00923 | |
| 0.031 | 0.868 | 0.243 | Lipocortins synthesis antagonist | 0.243 0.036 DBMET00401 | DBMET00401 | |
| 0.014 | 0.853 | 0.191 | Hypoglycemic | 0.191 0.121 DBMET00923 | DBMET00923 | |
| 0.013 | 0.864 | 0.409 | Apoptosis agonist | 0.409 0.11 DBMET00401 | DBMET00401 | |
| 0.053 | 0.917 | 0.257 | Calcium channel L-type activator | 0.257 0.197 DBMET00401 | DBMET00401 | |
| 0.022 | 0.896 | 0.304 | Folate antagonist | 0.304 0.003 DBMET00401 | DBMET00401 | |
| 0.004 | 0.885 | 0.956 | Tubulin antagonist | 0.956 0.003 DBMET00401 | DBMET00401 | |
| 0.01 | 0.912 | 0.228 | Immunosuppressant | 0.228 0.168 DBMET00401 | DBMET00401 | |
| 0.002 | 0.921 | 0.03 | Squalene synthetase inhibitor | 0.03 0.024 DBMET00401 | DBMET00401 | |
| 0.002 | 0.94 | 0.099 | Antineoplastic antibiotic | 0.099 0.047 DBMET00401 | DBMET00401 | |
| 0.003 | 0.944 | 0.57 | Alpha tubulin antagonist | 0.57 0.004 DBMET00401 | DBMET00401 | |
| 0.013 | 0.953 | 0.059 | Lipocortins synthesis agonist | 0.059 0.037 DBMET00401 | DBMET00401 | |
| 0.015 | 0.964 | 0.164 | Sigma receptor agonist | 0.164 0.076 DBMET00401 | DBMET00401 | |
| 0.004 | 0.979 | 0.797 | Antimitotic | 0.797 0.004 DBMET00401 | DBMET00401 | |
| 0.002 | 0.979 | 0.715 | Beta tubulin antagonist | 0.715 0.003 DBMET00401 | DBMET00401 | |
| 0.004 | 0.982 | 0.476 | P-glycoprotein inhibitor | 0.476 0.01 DBMET00401 | DBMET00401 | |
| 0.003 | 0.984 | 0.139 | Topoisomerase I inhibitor | 0.139 0.046 DBMET00401 | DBMET00401 | |
| 0.003 | 0.987 | 0.073 | Opioid kappa receptor antagonist | 0.073 0.07 DBMET00401 | DBMET00401 | |
| 0.004 | 0.995 | 0.858 | Antineoplastic alkaloid | 0.858 0 DBMET00401 | DBMET00401 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |